207 related articles for article (PubMed ID: 14699120)
21. Src tyrosine kinases mediate crystalline silica-induced NF-kappaB activation through tyrosine phosphorylation of IkappaB-alpha and p65 NF-kappaB in RAW 264.7 macrophages.
Kang JL; Jung HJ; Lee K; Kim HR
Toxicol Sci; 2006 Apr; 90(2):470-7. PubMed ID: 16431847
[TBL] [Abstract][Full Text] [Related]
22. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
[TBL] [Abstract][Full Text] [Related]
23. Tyr394 and Tyr505 are autophosphorylated in recombinant Lck protein-tyrosine kinase expressed in Escherichia coli.
Jullien P; Bougeret C; Camoin L; Bodeus M; Durand H; Disanto JP; Fischer S; Benarous R
Eur J Biochem; 1994 Sep; 224(2):589-96. PubMed ID: 7523116
[TBL] [Abstract][Full Text] [Related]
24. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Dell'Era P; Mohammadi M; Presta M
Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation.
Kwon J; Devadas S; Williams MS
Free Radic Biol Med; 2003 Aug; 35(4):406-17. PubMed ID: 12899942
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
[TBL] [Abstract][Full Text] [Related]
28. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
29. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation.
Cameron SJ; Malik S; Akaike M; Lerner-Marmarosh N; Yan C; Lee JD; Abe J; Yang J
J Biol Chem; 2003 May; 278(20):18682-8. PubMed ID: 12637502
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis.
Manna SK; Sah NK; Aggarwal BB
J Biol Chem; 2000 May; 275(18):13297-306. PubMed ID: 10788436
[TBL] [Abstract][Full Text] [Related]
31. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
32. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.
Tapinos N; Rambukkana A
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9188-93. PubMed ID: 15967991
[TBL] [Abstract][Full Text] [Related]
33. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
Tran H; Maurer F; Nagamine Y
Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
[TBL] [Abstract][Full Text] [Related]
35. Calcium-induced ERK activation in human T lymphocytes occurs via p56(Lck) and CaM-kinase.
Franklin RA; Atherfold PA; McCubrey JA
Mol Immunol; 2000 Aug; 37(11):675-83. PubMed ID: 11164895
[TBL] [Abstract][Full Text] [Related]
36. T cell receptor-induced phosphorylation of Sos requires activity of CD45, Lck, and protein kinase C, but not ERK.
Zhao H; Li YY; Fucini RV; Ross SE; Pessin JE; Koretzky GA
J Biol Chem; 1997 Aug; 272(34):21625-34. PubMed ID: 9261185
[TBL] [Abstract][Full Text] [Related]
37. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
38. The Src family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95.
Reinehr R; Becker S; Höngen A; Haüssinger D
J Biol Chem; 2004 Jun; 279(23):23977-87. PubMed ID: 15039424
[TBL] [Abstract][Full Text] [Related]
39. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
40. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
Puricelli L; Proietti CJ; Labriola L; Salatino M; Balañá ME; Aguirre Ghiso J; Lupu R; Pignataro OP; Charreau EH; Bal de Kier Joffé E; Elizalde PV
Int J Cancer; 2002 Aug; 100(6):642-53. PubMed ID: 12209601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
